Vor Biopharma (VOR) Total Non-Current Liabilities (2024 - 2026)

Vor Biopharma (VOR) has 3 years of Total Non-Current Liabilities data on file, last reported at $18.7 million in Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $18.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $18.7 million (changed N/A YoY), and the FY2025 annual result was $27.9 million, down 39.67% from the prior year.
• Total Non-Current Liabilities retreated to $18.7 million in Q1 2026 per VOR's latest filing, from $27.9 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $58.8 million in Q2 2025 and troughed at $18.7 million in Q1 2026.
• A 3-year average of $34.6 million and a median of $27.9 million in 2025 frame the typical range for Total Non-Current Liabilities.
• On a YoY basis, Total Non-Current Liabilities climbed as much as 39.67% in 2025 and fell as far as 39.67% in 2025.
• A 3-year view of Total Non-Current Liabilities shows it stood at $46.2 million in 2024, then slumped by 39.67% to $27.9 million in 2025, then sank by 32.92% to $18.7 million in 2026.
• Business Quant data shows VOR's Total Non-Current Liabilities at $18.7 million in Q1 2026, $27.9 million in Q4 2025, and $21.6 million in Q3 2025.